These results suggested that the depletion of STAT3 might partially counteract the anti-tumor effect of PTPRO, providing valuable insights into the interplay between PTPRO and JAK2/STAT3 pathway in cancer progression. This evidence concerns the gene STAT3 and neoplasm.